0000899243-22-026345.txt : 20220719
0000899243-22-026345.hdr.sgml : 20220719
20220719163433
ACCESSION NUMBER: 0000899243-22-026345
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220715
FILED AS OF DATE: 20220719
DATE AS OF CHANGE: 20220719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greenberg Bruce
CENTRAL INDEX KEY: 0001928391
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36332
FILM NUMBER: 221091915
MAIL ADDRESS:
STREET 1: C/O ALDEYRA THERAPEUTICS, INC.
STREET 2: 131 HARTWELL AVENUE, SUITE 320
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aldeyra Therapeutics, Inc.
CENTRAL INDEX KEY: 0001341235
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 131 HARTWELL AVENUE
STREET 2: SUITE 320
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-761-4904
MAIL ADDRESS:
STREET 1: 131 HARTWELL AVENUE
STREET 2: SUITE 320
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: Aldexa Therapeutics, Inc.
DATE OF NAME CHANGE: 20130102
FORMER COMPANY:
FORMER CONFORMED NAME: Neuron Systems Inc
DATE OF NAME CHANGE: 20051012
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-15
0
0001341235
Aldeyra Therapeutics, Inc.
ALDX
0001928391
Greenberg Bruce
C/O ALDEYRA THERAPEUTICS, INC.
131 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
See Remarks
Common Stock
2022-07-15
4
A
0
126087
0.00
A
133900
D
Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on July 15, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.
Interim Chief Financial Officer
/s/ Bruce Greenberg
2022-07-19